Drug intelligence / Profile preview

vitamin a

Development stage
Approved
Lead developer
Robinson Pharma
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Topical, Ophthalmic
01

Overview

Vitamin A is an essential fat-soluble vitamin that encompasses a group of related compounds including retinol (the alcohol form), retinal (the aldehyde form), and several provitamin carotenoids such as beta-carotene. It is crucial for vision (as it forms rhodopsin in the retina), immune function, reproduction, cellular growth and differentiation (especially epithelial tissue), bone development and hematopoiesis. Vitamin A acts primarily through its active metabolite all-trans-retinoic acid which binds to nuclear receptors—retinoic acid receptors (RARs) and retinoid-X receptors (RXRs)—to regulate gene transcription. It is used clinically to prevent or treat vitamin A deficiency disorders such as xerophthalmia and night blindness[1][3][5]. Vitamin A also has antioxidant properties[1][2].

Brand names
Aquasol AInfuviteInfuvite PediatricMvc-fluorideMvi PediatricVitafol-oneA-25A25A 25A/Fish OilXcellent A 3000Xcellent A
Other names
retinolretinoic acidretinyl esters
02

Targets

RARA (Retinoic acid receptor alpha)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)RXRA (Retinoid X receptor alpha)RXRB (Retinoid X receptor beta)RXRG (RXRγ)RAR (Retinoic acid receptor)RHO (Rhodopsin)

Beyond the preview

Go deeper on vitamin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin a.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call